Rice Derica W 4

What Happened Derica W. Rice, a director of Bristol Myers Squibb (BMY), received an award of 672.51 deferred share units on 2026-06-30. The units are reported at a grant price of $57.62 each for a total reported value of $38,750. This transaction is an award/grant (derivative), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-30; Filing date: 2026-07-02 (appears timely—within standard Form 4 filing window).
• Grant details: 672.51 Deferred Share Units (DSUs) at $57.62 per unit; reported aggregate value $38,750.
• Post-transaction holdings: Not specified in the filing.
• Footnotes:
  • F1: Each Deferred Share Unit will convert into one share of common stock upon settlement; DSUs become settleable when the director ceases to be a director or on a future date previously specified by the reporting person.
  • F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
• Transaction code: A = Award/Grant (derivative).

Context Deferred share units for non-employee directors are a common form of compensation and represent future claims on company stock rather than an immediate cash or market purchase. These grants are routine and do not by themselves indicate a director buying or selling stock for speculative reasons; they convert to actual shares only upon settlement per the plan terms.